Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $9.4300 (-6.26%) ($9.4200 - $10.2400) on Wed. Feb. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.64% (three month average) | RSI | 37 | Latest Price | $9.4300(-6.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(72%) IBB(70%) ARKK(66%) IBUY(62%) | Factors Impacting TGTX price | TGTX will decline at least -4.32% in a week (0% probabilities). VIXM(-48%) VXX(-41%) UUP(-26%) TBT(-11%) USO(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.32% (StdDev 8.64%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.11(-196.61%) | Resistance Level | $10.58 | 5 Day Moving Average | $10.42(-9.5%) | 10 Day Moving Average | $10.44(-9.67%) | 20 Day Moving Average | $10.58(-10.87%) | To recent high | -62.5% | To recent low | 11.3% | Market Cap | $1.194b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |